(lp0
S'Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy ... PR Newswire  - Mar 14, 2017 SAN DIEGO, March 14, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Biocept  Enters Collaboration to Provide Liquid Biopsy Testing for Small ... - StreetInsider.com'
p1
aS'Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and ... PR Newswire  - Feb 21, 2017 SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that ...'
p2
aS'Valeant Pharmaceuticals Intl Inc  Running Low On Gas, Biocept Inc (BIOC ... Smarter Analyst - Mar 8, 2017 In the biotech-verse, Valeant Pharmaceuticals Intl Inc  and Biocept Inc  are in opposite standing. According to one of the best analysts on the Street, who has lately been zooming in with a vengeance on the troubled biotech giant ...Wall Street Movers News  Valeant Pharmaceuticals Intl Inc , Biocept ... - Wall Street Times '
p3
aS'Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer ... PR Newswire  - 18 hours ago SAN DIEGO, March 20, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Global Liquid Biopsy Market is Growing at CAGR of 21.6% and Expected to Reach ... - EIN News '
p4
aS'Biocept Inc  Stockholders Get Letter From The CEO Journal Transcript - Feb 27, 2017 A letter sent by the Michael Nall, the chief executive officer of Biocept Inc , to shareholders has sought to underscore the strong position the pharmaceutical company is currently in, in the area of liquid biopsy.'
p5
aS"Running Mover to Focus: Biocept, Inc.'s  stock price is Worth at $2.20 Hot Stocks Point - 15 hours ago Biocept, Inc. , a part of Healthcare sector and belongs to Medical Laboratories &amp; Research industry; ended its day with gain 3.77% and finalized at the price of $2.20.Are Biocept, Inc.  Shares Heading Higher? - Rockville Register"
p6
aS'Biocept, Inc.  EPS Estimate At $-0.19 Transcript Daily - 10 hours ago Analysts are expecting Biocept, Inc.  to report mean EPS of $-0.19 for the quarter ending 2017-03-31. Financial report can come on 2017-05-11.'
p7
aS"Buy, Sell or Hold? Analysts Approach: Biocept, Inc. , Avon Products, Inc ... The USA Commerce - Mar 9, 2017 Shares of Biocept, Inc.  surged 0.44% to $2.27. During the trading on 03/08/2017, Company's stock ranged from $2.23 to $2.75."
p8
aS'Hot Stocks Report: Biocept, Inc. , Towerstream Corporation  Post Analyst - Mar 17, 2017 Biocept, Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 22.56% of shares outstanding.'
p9
aS"Analyst's Proposition on Biocept, Inc. , W&amp;T Offshore, Inc.  The USA Commerce - Mar 15, 2017 Shares of Biocept, Inc.  surged 3.43% to $2.11. During the trading on 03/14/2017, Company's stock ranged from $2.04 to $2.22."
p10
a.